Research
New Phase 3 Trial Planned for Nebokitug in PSC
A new trial is planned for PSC
Read MoreSPRING Clinical Trial Update
Clinical Data from Phase 2 SPRING Trial Shows CM-101 Demonstrated Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Activity across Multiple Components of PSC.
Read MorePromising Preclinical Data from Rectify Pharma
Rectify Pharma presented promising preclinical data for RTY-694, their lead candidate for treating primary sclerosing cholangitis and other hepatobiliary diseases, at the 75th Annual Liver Meeting® 2024.
Read MoreIs the Asp-PSC Study Open Near You?
Sign up for an alert when the Asp-PSC Study is recruiting near you.
Read MoreNGM Bio Announces Plans for a New Clinical Trial
NGM Bio has announced plans for a new clinical trial to evaluate a medicine called aldafermin in PSC.
Read MorePositive Results Announced from SPRING Trial
Positive results from the SPRING Clinical Trial announced today
Read MoreFirst Participant in FARGO Trial
A PSC Support Trustee has been diagnosed with both PSC and inflammatory bowel disease (IBD). They is receiving weekly poo transplants to treat the conditions in a world first trial.
Read MoreMore Encouraging Data from the INTEGRIS Clinical Trial
Pliant Therapeutics announce latest results from the INTEGRIS Clinical Trial
Read MoreMore Mission 2030 Research Announced
PSC Support has awarded £52,500 to Dr Anthony George to uncover the processes that drive inflammation and damage in PSC.
Read MoreResearch Chat
If you have small duct PSC or an uncertain PSC diagnosis can you help us?
Read More